UK markets open in 6 hours 59 minutes
NIKKEI 225
38,855.37 -44.63 (-0.11%) HANG SENG
18,821.16 -6.14 (-0.03%) CRUDE OIL
80.24 +0.41 (+0.51%) GOLD FUTURES
2,360.10 +3.60 (+0.15%) DOW
38,852.86 -216.74 (-0.55%) Bitcoin GBP
53,554.18 -830.25 (-1.53%)
Merck & Co., Inc. (6MK.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:07PM CEST
| Previous close | 119.60 |
| Open | 118.60 |
| Bid | 115.60 x 100000 |
| Ask | 115.80 x 100000 |
| Day's range | 116.20 - 118.60 |
| 52-week range | 90.70 - 123.20 |
| Volume | |
| Avg. volume | 329 |
| Market cap | 294.313B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 140.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.84 (2.38%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Business Wire
Merck Announces Third-Quarter 2024 Dividend
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend
- Business Wire
Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)
RAHWAY, N.J., May 28, 2024--Merck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer
- Business Wire
Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
RAHWAY, N.J., May 15, 2024--Merck to Present New Data at 2024 ASCO Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
© 2024 Yahoo. All rights reserved.